BRIEF-Achillion announces clinical milestone for the advancement of JNJ-4178 By: Reuters: Company News December 28, 2016 at 06:43 AM EST * Achillion announces clinical milestone for the advancement of JNJ-4178 in phase 2B development for chronic HCV Read More >> Related Stocks: Achison Inc Johnson & Johnson